For researchers, this means: Published Phase 3 trial data available for reference Well-characterized safety profile from prescription use Ongoing clinical trials for additional indications (NAFLD, cognitive function) Clear differentiation from research-only peptides like BPC-157 or TB-500 For comprehensive information on FDA-approved peptides across all therapeutic categories, see our FDA Approved Peptides List 2026 guide
You should always consult with a qualified physician or health professional about your specific circumstances
10.2337/diabetes.53.1.5 [DOI] [PMC free article] [PubMed] [Google Scholar] Hviid, A
Supports Liver Health: Aid natural detoxification processes and protect liver cells from oxidative damage
However, sometimes improvements to user experience come from combining devices with digital technologies, such as smartphone apps, without changing the injection device itself
doi:10.2147/PPA.S106821 BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury